Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText.
Kick-your-searchterm to multiple Engines kick-your-query now !>
A dictionary by aggregated review articles of nephrology, medicine and the life sciences
Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

suck abstract from ncbi


10.1007/s00401-013-1185-7

http://scihub22266oqcxt.onion/10.1007/s00401-013-1185-7
suck pdf from google scholar
24100688/?report=reader!3887147!24100688
unlimited free pdf from europmc24100688    free
PDF from PMC    free
html from PMC    free

suck abstract from ncbi

pmid24100688      Acta+Neuropathol 2013 ; 126 (5): 643-57
Nephropedia Template TP

gab.com Text

Twit Text FOAVip

Twit Text #

English Wikipedia


  • Cerebral amyloid PET imaging in Alzheimer s disease #MMPMID24100688
  • Jack CR Jr; Barrio JR; Kepe V
  • Acta Neuropathol 2013[Nov]; 126 (5): 643-57 PMID24100688show ga
  • The devastating effects of the still incurable Alzheimer's disease (AD) project an ever increasing shadow of burden on the health care system and society in general. In this ominous context, amyloid (Abeta) imaging is considered by many of utmost importance for progress towards earlier AD diagnosis and for potential development of effective therapeutic interventions. Amyloid imaging positron emission tomography procedures offer the opportunity for accurate mapping and quantification of amyloid-Abeta neuroaggregate deposition in the living brain of AD patients. This review analyzes the perceived value of current Abeta imaging probes and their clinical utilization and, based on amyloid imaging results, offers a hypothesis on the effects of amyloid deposition on the biology of AD and its progression. It also analyzes lingering questions permeating the field of amyloid imaging on the apparent contradictions between imaging results and known neuropathology brain regional deposition of Abeta aggregates. As a result, the review also discusses literature evidence as to whether brain Abeta deposition is truly visualized and measured with these amyloid imaging agents, which would have significant implications in the understanding of the biological AD cascade and in the monitoring of therapeutic interventions with these surrogate Abeta markers.
  • |Alzheimer Disease/*diagnostic imaging/metabolism/pathology[MESH]
  • |Amyloid beta-Peptides/analysis/*metabolism[MESH]
  • |Brain/*diagnostic imaging/pathology[MESH]
  • |Disease Progression[MESH]
  • |Humans[MESH]


  • DeepDyve
  • Pubget Overpricing
  • suck abstract from ncbi

    Linkout box